Cargando…

FRI554 Pretibial Myxedema Associated With Hashimoto Thyroiditis Treated With Teprotumumab

Disclosure: E.M. Niedzialkowska: None. B. Ajaz: None. A. Pokharel: None. Introduction: Pretibial myxedema (PTM) is a localized thyroid-associated dermopathy characterized by local thickening of the skin of the lower extremities. It mostly develops after the onset of thyroid eye disease (TED). Majori...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marta Niedzialkowska, Ewelina, Ajaz, Banka, Pokharel, Ashbita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554456/ http://dx.doi.org/10.1210/jendso/bvad114.1898

Ejemplares similares

Teprotumumab for Treatment of Pretibial Myxedema
por: Reyes, Michelangelo P, et al.
Publicado: (2023)

A case of pretibial myxedema treated with teprotumumab
por: Petit, Lauren, et al.
Publicado: (2021)

SAT-554 Teprotumumab in Graves' Orbitopathy: Extended Outcome Analyses
por: Kahaly, George, et al.
Publicado: (2019)

Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab
por: Bowens, Brendan K., et al.
Publicado: (2022)

Resolution of pretibial myxedema with teprotumumab in a patient with Graves disease
por: Varma, Aakaash, et al.
Publicado: (2020)

FRI572 Teprotumumab In Unexplored Presentation Of Thyroid Eye Disease
por: Torres Torres, Marina T, et al.
Publicado: (2023)

SAT-471 A Rare Case of Pretibial Myxedema Preceding Graves’ Hyperthyroidism
por: Bao, Ginny W, et al.
Publicado: (2020)

PSAT358 Graves’ Disease Complicated by Post-Operative Graves’ Ophthalmopathy and Pretibial Myxedema
por: Bowens, Brendan, et al.
Publicado: (2022)

ODP502 Nodular Pretibial Myxedema without Graves’ Orbitopathy: A Case Report
por: Veeramachaneni, Ravali, et al.
Publicado: (2022)

FRI548 A Case Of Periureteric Myxedema
por: Ferris, Jaclyn M, et al.
Publicado: (2023)

SUN-576 Abrupt Switching From Hypertyroidism To Hypothyroidism With Pretibial Myxedema And Acropachy, In Graves’ Ophthalmopathy: Case Report.
por: Ferreira, Eduardo, et al.
Publicado: (2019)

ODP531 Worsening of pretibial myxedema following repeated doses of radioiodine treatment in a patient with hyperthyroid Graves’ disease
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2022)

FRI568 Hashimoto’s Thyroiditis With Negative Antibodies In Association With Common Variable Immunodeficiency
por: Ebrahim, Ismail C, et al.
Publicado: (2023)

FRI502 Myxedema Coma With An Unusual Pattern Of Thyroid Function Tests Due To Amiodarone-induced Hypothyroidism
por: Nguyen, Son, et al.
Publicado: (2023)

Hearing Loss and Teprotumumab
por: Kossler, Andrea, et al.
Publicado: (2021)

FRI560 A Rare Case Of Hashimoto Encephalopathy
por: Nokhbehzaeim, Mahrokh, et al.
Publicado: (2023)

Pretibial myxedema successfully treated with intralesional hyaluronidase
por: Hoesly, Paul M., et al.
Publicado: (2018)

Pretibial myxedema treated with intralesional hyaluronidase and triamcinolone
por: Kudlak, Natalie, et al.
Publicado: (2020)

FRI552 Orbitopathy As The Sole Manifestation Of Hashimoto’s Thyroiditis In A Euthyroid Patient: A Case Report
por: Labib, Christine, et al.
Publicado: (2023)

FRI482 Severe Hypothyroidism: A Lack Of Standardized Care For Patients At Risk Of Myxedema Coma
por: Abdurrahman, Selma, et al.
Publicado: (2023)

FRI549 The See-Saw Theory - Hypothyroidism Due To Hashimoto's Thyroiditis Followed By Hyperthyroidism Due To Graves' Disease
por: Sharma, Pranjali
Publicado: (2023)

PSAT265 Blood Glucose in Thyroid Eye Disease (TED) in Patients treated with Teprotumumab: Clinical Trials Data
por: Smith, Terry J, et al.
Publicado: (2022)

RF35 | PSAT263 Efficacy of Teprotumumab for Thyroid Eye Disease in Hypothyroid Patients
por: Smith, Terry J, et al.
Publicado: (2022)

PSAT261 Use of Steroids Pre- and Post-Teprotumumab in Thyroid Eye Disease Patients
por: Holt, Robert J, et al.
Publicado: (2022)

Pretibial Myxedema Presenting as Severe Elephantiasis
por: Lee, Jae-Hoon, et al.
Publicado: (2018)

SAT461 Hearing-related Issues Associated With Graves’ Disease, Thyroid Eye Disease And Treatment With Teprotumumab
por: Smith, Terry J, et al.
Publicado: (2023)

LBSAT238 Teprotumumab Reduces Orbital Fat And Muscle Volume In Patients With Thyroid Eye Disease
por: Ugradar, Shoaib
Publicado: (2022)

SUN-LB89 Resolution of Hashimoto Thyroiditis: A Case of Hashimoto Thyroiditis Evolving Into Subacute Thyroiditis and Euthyroidism
por: Leong, Jaclyn, et al.
Publicado: (2020)

MON-626 Survey of Thyroid Antibody Positivity and Treated Hashimoto’s Disease in Nodular Thyroid Disorders
por: Unjom, Zubina, et al.
Publicado: (2019)

Treatment of pretibial myxedema with intralesional immunomodulating therapy
por: Ren, Ziwei, et al.
Publicado: (2017)

Elephantiasic Pretibial Myxedema with Involvement of the Buttocks and Face
por: Wang, Ya-Nan, et al.
Publicado: (2017)

FRI561 The Thyroid Trifecta
por: Kachhadia, Palak, et al.
Publicado: (2023)

SUN-550 Pressor Refractory, Liothyronine Responsive Myxedema Cardiogenic Shock without Myxedema Coma
por: Willis, Cornelia, et al.
Publicado: (2019)

SAT-460 Myxedema Coma Mimicking Cardiogenic Shock Treated with Levothyroxine
por: Chaker, Bayan, et al.
Publicado: (2020)

SAT570 Thyroid Lymphoma In A Patient With Hashimoto’s Thyroiditis
por: Aggarwal, Tanya, et al.
Publicado: (2023)

PSAT293 Uncommon Presentation of Hashimoto Thyroiditis
por: Alzenaidi, Ahlam
Publicado: (2022)

SAT554 Follicular Variant of PTCA Initially Presenting with Widespread Metastases
por: Natividad Bisquera, Nichole Andrea, et al.
Publicado: (2023)

A Randomized Controlled Trial of Intralesional Glucocorticoid for Treating Pretibial Myxedema
por: Lan, Changgui, et al.
Publicado: (2015)

Myxedema Coma Disguised as Alcohol Withdrawal
por: Pahwa, Dhivya, et al.
Publicado: (2021)

COVID-19 Induced Myxedema Madness
por: Tal, Noa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pabludlpi71pcecsvgea0u9854